Literature DB >> 16227428

Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4+ T lymphocyte decline.

Paul M Thompson1, Rebecca A Dutton, Kiralee M Hayashi, Arthur W Toga, Oscar L Lopez, Howard J Aizenstein, James T Becker.   

Abstract

HIV/AIDS infection is the fourth leading cause of death worldwide, and one in every 100 adults aged 15-49 years is HIV-infected. Forty percent of AIDS patients suffer from neurological symptoms, but the selective profile of damage caused by HIV in the brain is not well understood. Here, we report 3D maps revealing how AIDS affects the human cerebral cortex, identifying the most vulnerable regions and where deficits link with cognitive decline and immune-system suppression. With high-resolution brain MRI scans, we created composite maps of cortical gray-matter thickness in 26 AIDS patients and 14 healthy controls to establish the selective pattern of brain deficits in AIDS. In AIDS, primary sensory, motor, and premotor cortices were 15% thinner. Thinner frontopolar and language cortex correlated with immune system deterioration measured through blood levels of CD4+ T lymphocytes. Prefrontal and parietal tissue loss correlated with cognitive/motor deficits. T cell depletion and cognitive impairment are, therefore, associated with specific 3D brain-deficit patterns visualized with MRI. These quantitative MRI-based maps reveal that HIV selectively damages the cortex. They provide an approach to gauge the impact of AIDS on the living brain and show that the brain is still vulnerable to infection even when patients are receiving antiretroviral therapy.

Entities:  

Mesh:

Year:  2005        PMID: 16227428      PMCID: PMC1266080          DOI: 10.1073/pnas.0502548102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Deficits of NMDA receptors and glutamate uptake sites in the frontal cortex in AIDS.

Authors:  A M Sardar; P H Hutson; G P Reynolds
Journal:  Neuroreport       Date:  1999-11-26       Impact factor: 1.837

2.  HIV-related neuropathology, 1985 to 1999: rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy.

Authors:  Jutta K Neuenburg; Hans R Brodt; Brian G Herndier; Markus Bickel; Peter Bacchetti; Richard W Price; Robert M Grant; Wolfgang Schlote
Journal:  J Acquir Immune Defic Syndr       Date:  2002-10-01       Impact factor: 3.731

3.  Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine.

Authors:  A Nath; N J Haughey; M Jones; C Anderson; J E Bell; J D Geiger
Journal:  Ann Neurol       Date:  2000-02       Impact factor: 10.422

4.  The unveiling of traumatic brain injury in an HIV/AIDS population.

Authors:  M P Jaffe; J O'Neill; D Vandergoot; W A Gordon; B Small
Journal:  Brain Inj       Date:  2000-01       Impact factor: 2.311

5.  Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis.

Authors:  M Cherner; E Masliah; R J Ellis; T D Marcotte; D J Moore; I Grant; R K Heaton
Journal:  Neurology       Date:  2002-11-26       Impact factor: 9.910

6.  Correlation between percentage of brain parenchymal volume and neurocognitive performance in HIV-infected patients.

Authors:  Sohil H Patel; Dennis L Kolson; Guila Glosser; Isabel Matozzo; Yulin Ge; James S Babb; Lois J Mannon; Robert I Grossman
Journal:  AJNR Am J Neuroradiol       Date:  2002-04       Impact factor: 3.825

7.  Elevated cerebrospinal fluid quinolinic acid levels are associated with region-specific cerebral volume loss in HIV infection.

Authors:  M P Heyes; R J Ellis; L Ryan; M E Childers; I Grant; T Wolfson; S Archibald; T L Jernigan
Journal:  Brain       Date:  2001-05       Impact factor: 13.501

8.  AIDS does not alter the total number of neurons in the hippocampal formation but induces cell atrophy: a stereological study.

Authors:  M J Sá; M D Madeira; C Ruela; B Volk; A Mota-Miranda; H Lecour; V Gonçalves; M M Paula-Barbosa
Journal:  Acta Neuropathol       Date:  2000-06       Impact factor: 17.088

9.  Prevalence of cognitive disorders differs as a function of age in HIV virus infection.

Authors:  James T Becker; Oscar L Lopez; Mary Amanda Dew; Howard J Aizenstein
Journal:  AIDS       Date:  2004-01-01       Impact factor: 4.177

10.  Correlation of in vivo neuroimaging abnormalities with postmortem human immunodeficiency virus encephalitis and dendritic loss.

Authors:  Sarah L Archibald; Eliezer Masliah; Christine Fennema-Notestine; Thomas D Marcotte; Ronald J Ellis; J Allen McCutchan; Robert K Heaton; Igor Grant; Margaret Mallory; Aida Miller; Terry L Jernigan
Journal:  Arch Neurol       Date:  2004-03
View more
  183 in total

Review 1.  Differentiating HIV-Associated Neurocognitive Disorders From Alzheimer's Disease: an Emerging Issue in Geriatric NeuroHIV.

Authors:  Benedetta Milanini; Victor Valcour
Journal:  Curr HIV/AIDS Rep       Date:  2017-08       Impact factor: 5.071

Review 2.  The role of medical imaging in defining CNS abnormalities associated with HIV-infection and opportunistic infections.

Authors:  David F Tate; Rola Khedraki; Daniel McCaffrey; Daniel Branson; Jeffrey Dewey
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

3.  Combined effects of aging and HIV infection on semantic verbal fluency: a view of the cortical hypothesis through the lens of clustering and switching.

Authors:  Jennifer E Iudicello; Steven Paul Woods; Reena Deutsch; Igor Grant
Journal:  J Clin Exp Neuropsychol       Date:  2012-01-31       Impact factor: 2.475

4.  Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.

Authors:  A V Kabanov; H E Gendelman
Journal:  Prog Polym Sci       Date:  2007       Impact factor: 29.190

5.  Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era.

Authors:  Ronald A Cohen; Jaroslaw Harezlak; Giovanni Schifitto; George Hana; Uraina Clark; Assawin Gongvatana; Robert Paul; Michael Taylor; Paul Thompson; Jeffery Alger; Mark Brown; Jianhui Zhong; Thomas Campbell; Elyse Singer; Eric Daar; Deborah McMahon; Yuen Tso; Constantin T Yiannoutsos; Bradford Navia
Journal:  J Neurovirol       Date:  2010-02       Impact factor: 2.643

Review 6.  Thinking about HIV: the intersection of virus, neuroinflammation and cognitive dysfunction.

Authors:  K Grovit-Ferbas; M E Harris-White
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

Review 7.  Genetic, transcriptomic, and epigenetic studies of HIV-associated neurocognitive disorder.

Authors:  Andrew J Levine; Stella E Panos; Steve Horvath
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-01       Impact factor: 3.731

8.  [3H]Dopamine Uptake through the Dopamine and Norepinephrine Transporters is Decreased in the Prefrontal Cortex of Transgenic Mice Expressing HIV-1 Transactivator of Transcription Protein.

Authors:  Matthew Strauss; Bernadette O'Donovan; Yizhi Ma; Ziyu Xiao; Steven Lin; Michael T Bardo; Pavel I Ortinski; Jay P McLaughlin; Jun Zhu
Journal:  J Pharmacol Exp Ther       Date:  2020-05-27       Impact factor: 4.030

Review 9.  Cortical consequences of HIV-1 Tat exposure in rats are enhanced by chronic cocaine.

Authors:  Wesley N Wayman; Lihua Chen; Amanda L Persons; T Celeste Napier
Journal:  Curr HIV Res       Date:  2015       Impact factor: 1.581

10.  Apathy correlates with cognitive performance, functional disability, and HIV RNA plasma levels in HIV-positive individuals.

Authors:  Miriam E Shapiro; Jeannette R Mahoney; Barry S Zingman; David L Pogge; Joe Verghese
Journal:  J Clin Exp Neuropsychol       Date:  2013-10-04       Impact factor: 2.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.